Effects of polymorphisms in ovine and caprine prion protein alleles on cell-free conversion by Eiden, Martin et al.
RESEARCH Open Access
Effects of polymorphisms in ovine and caprine
prion protein alleles on cell-free conversion
Martin Eiden
1, Elizabeth Ortega Soto
1, Thomas C Mettenleiter
2, Martin H Groschup
1*
Abstract
In sheep polymorphisms of the prion gene (PRNP) at the codons 136, 154 and 171 strongly influence the
susceptibility to scrapie and bovine spongiform encephalopathy (BSE) infections. In goats a number of other gene
polymorphisms were found which are suspected to trigger similar effects. However, no strong correlation between
polymorphisms and TSE susceptibility in goats has yet been obtained from epidemiological studies and only a low
number of experimental challenge data are available at present. We have therefore studied the potential impact of
these polymorphisms in vitro by cell-free conversion assays using mouse scrapie strain Me7. Mouse scrapie brain
derived PrP
Sc served as seeds and eleven recombinant single mutation variants of sheep and goat PrP
C as
conversion targets. With this approach it was possible to assign reduced conversion efficiencies to specific
polymorphisms, which are associated to low frequency in scrapie-affected goats or found only in healthy animals.
Moreover, we could demonstrate a dominant-negative inhibition of prion polymorphisms associated with high
susceptibility by alleles linked to low susceptibility in vitro.
Introduction
Prion diseases include scrapie in sheep, bovine spongi-
form encephalopathy (BSE) in cattle and Creutzfeldt-
Jacob-Disease (CJD) in humans and are characterized by
the conversion of cellular prion protein (PrP
C)i n t oa n
abnormal pathological isoform called PrP
Sc. In the course
of the conversion the prion protein is transformed from a
predominantly a-helical structure into a b-sheet rich
conformation. Disease development is characterized by
an accumulation of PrP
Sc followed by neuronal degenera-
tion and CNS dysfunction. The PrP gene (PRNP)p o l y -
morphisms have been associated with distinct disease
phenotypes in humans and sheep. These phenotypes
include differences in the incubation period, PrP
Sc
deposition pattern, pathogenesis and even clinical signs
following the infection with a given strain or isolate.
Sheep carrying the PRNP polymorphisms valine (V) or
alanine (A) at codon 136 (136V and 136A) are highly sus-
ceptible to classical scrapie, while the exchange of argi-
nine (R) to histidine at codon 154 (154H) is linked to low
scrapie susceptibility [1,2]. Interestingly, this allele is
associated with high susceptibility to atypical/Nor98 scra-
pie in sheep and goats [3,4] and short incubation periods
in BSE infected sheep [5]. The exchange of glutamine (Q)
t oa r g i n i n e( R )a tc o d o n1 7 1( 1 7 1 R )i n d u c e san e a r l y
resistant phenotype [6,7]. Based on these findings a sheep
breeding program in Europe was carried out to propagate
the 171R allele [8].
Genetic analysis of the goat PRNP revealed 42 poly-
morphisms in the open reading frame including silent
mutations [9]. Some of these polymorphisms are asso-
ciated with changes in the susceptibility to scrapie: At
codon 142 an exchange from isoleucine (I) to methionine
(M) (142M) prolongs the incubation time after a chal-
lenge with scrapie and BSE prions [10]. A reduced sus-
ceptibility to natural scrapie has also been reported for
goats carrying arginine (R) at codon 143 (143R) and histi-
dine (H) at codon 154 (154H) [11] in the PRNP gene as
well as for goats with glutamine (Q) at codon 211 (211Q)
[12]. Recently, two novel polymorphism were found at
position 146, harboring serine (S) or aspartic acid (D)
(146S, 146D), which were linked to resistance against
scrapie [13]. In addition, lysine (K) at codon 222 (222K)
is only found in healthy goats and is associated with low
susceptibility to scrapie [14]. The caprine wildtype allele
contained isoleucin (I) at position 142, histidine (H) at
position 143, asparagine (N) at position 146, arginine (R)
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222 and was subsequently denoted IHNRRQ. Because of
the variety of mutations in the caprine PRNP gene, their
impact on the susceptibility is difficult to ascertain
experimentally in vivo.
To analyze the effect of single amino acid substitu-
tions on the convertibility of ovine and caprine prion
protein variants, an in vitro approach was therefore used
in this study. Several in-vitro assays were reported
before. The first assay that was reported used purified
and radiolabeled PrP
C molecules, which were incubated
with PrP
Sc seeds and converted into proteinase K resis-
tant PrP
res fragments [15-17]. This type of assay was
intensively used to analyze interspecies and intraspecies
transmission barriers [18]. Recently, a modified cell-free
conversion assay was established which uses both prion
components under equimolar and semi-native condi-
tions [19]. Another assay was published which dealt
with aggregation and fibrillation of recombinant prion
protein in the absence of PrP
Sc seeds [20]. However, the
infectious nature of the so-called “synthetic prions” still
remains enigmatic [21].
In this study we used a cell-free conversion assay to
evaluate PRNP polymorphisms in sheep and goats in
vitro. We therefore generated 11 bacterial prion variants
haboring different ovine and caprine PrP
C polymorph-
isms. The conversion was carried out with mouse pas-
saged scrapie strain Me7, which originated from classical
scrapie isolates [22]. Our results provide important clues
regarding impacts of aminoacid exchange on the conver-
sion of prion protein and demonstrate a high accordance
between our findings in vitro and epidemiological data.
Material and methods
Mutation of PRNP
Ovine prion alleles were amplified from the ORF 23-234
by PCR using primers ov1 (5’-CCGGATCCAAGAAGC-
GACC AAAACC-3’)a n do v 2( 5 ’-CCAAGCTTCTAG
CTGGATC TTCTCCCG-3’). As template we used geno-
mic DNA from genotyped homozygous sheep alleles
(136A, 154H and 171R) [23]. Caprine polymorphisms
were generated by the substitu-tion of amino acids at resi-
dues 142, 143, 146, 151, 211 and 222 using the ovine 136A
allele as a template. The caprine mutations were carried
out by a two step PCR which first uses internal primers
for the particular substitution and then external primers
ov1/ov2 for the amplification of the mutant template. The
142M mutation was introduced by the use of a forward
primer (forv) 5’-AGG CCT CTT ATG CAT TTT GGC-3’
and a reverse primer (rev) 5’-GCC AAA ATG CAT AAG
AGG CCT-3’, the 143R mutation with forv 5’-CCT CTT
ATA CGT TTT GGC AAT G-3’ and rev 5’-C AAT GCC
AAA ACG TAT AAG AGG-3’ primer, the 146S with forv
5’-CAT TTT GGC TCT GAC TAT GAG-3’ and rev
5’-CTC ATA GTC AGA GCC AAA ATG-3’ primer, the
146D with forv 5’-CAT TTT GGC GAT GAC TAT
GAG-3’ and rev 5’-CTC ATA GTC ATC GCC AAA
ATG-3’ primer, the 151H mutation with forv 5’-C TAT
GAG GAC CAT TAC TAT CG-3’ and rev 5’-CG ATA
G T AA T GG T CC T CA T AG - 3 ’ primer, 211Q with
forv 5’-GATA ATG GAG CAA GTG GTG GAG-3’ and
rev 5’-CTC CAC CAC TTG CTC CAT TAT C-3’ primer
and the 222K mutation with rev 5’-GG AAC CTT CTA
ACT TGC CCC CCT TTG GTA ATA AGC CTG GGA
TTC TCT CTT GTA CTG G-3’ primer.
Expression and purification of recombinant PrP
The amplified gene was cloned via BamHI and HindIII
restriction sites into the vector pQE-40 (Qiagen, Hilden,
Germany) which harbors an N-terminal histidin (his-)-tag.
Expression and purification was described previously [19].
In brief, purification was carried out under denaturating
conditions over an N-terminal His-tag using a Ni-NTA-
column according to standard procedures. Refolding was
accomplished by dialysis in the corresponding refolding
buffer [24]. CD spectra of all constructs displayed a high
content of a-helical structure, which indicates proper fold-
ing of the proteins (data not shown).
Cell-free conversion assay
Cell-free conversion was carried out by mixing 400 ng of
recombinant prion protein with 400 ng purified PrP
Sc
seeds (mouse passaged scrapie strain Me7) in a modified
conversion buffer (50 mM citrate pH 6.0, 200 mM KCl,
5m MM g C l 2, 1.25% N-lauroylsarcosine and 2.0 μg/μL
suramine). After three days of incubation at 37 °C the
samples were treated with Proteinase K (PK) for 1 h at
37 °C at a final concentration of 30 μ/mL (in 50 mM Tris/
HCl, pH 7.4, 150 mM NaCl). The reaction was stopped
with 10 mM Phenylmethylsulfonylfluorid (PMSF). Thyreo-
globuline was added to the samples, which were subse-
quently incubated in methanol at -20 °C for at least 1 h
[19]. Proteins were pelleted by centrifugation at 13 000
rounds per minute (rpm) for 15 min and subjected to
sodium dodecyl sulphate-polyacrylamide gel electrophor-
esis (SDS-PAGE). PrP
Sc was purified from terminally scra-
pie diseased mouse brains (mouse scrapie Me7) according
to a previous publication [19]. Detection of the newly con-
verted PrP
res fragments was accomplished by immunoblot-
ting, using mab P4 [25] as detection antibody and a
chemiluminiscence visualisation. Chemiluminescence sig-
nals were detected using the BioRad VersaDoc™ photo
imaging system and analysed with the Quantity One quan-
tification software (BioRad, Munich, Germany). All con-
structs were analysed in a cell-free conversion assay and
the conversion rates of PrP variants were calculated on the
basis of the generated PrP
res fragments. Relative conver-
sion rates of ovine PrP variants were calculated in relation
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derived variants in relation to the caprine IHNRRQ refer-
ence allele (n = 8). Statistical analysis was performed with
unpaired student t-test and statistical significance was
expressed as follows: ns: not significant, *: p < 0.05, **: p <
0.01, ***: p < 0.001. In the case of unequal statistical spread
of variances, Student’s t-test was supplemented by the
Welch correction (Welch’s t-test).
Results
Figure 1 shows the conversion of recombinant prokaryo-
tic ovine prion protein (136A allele) into its PK resistant
form, PrP
res (Figure 1A, lane 2). The shift of approxi-
mately 6-7 kDa (in comparison to the nontreated con-
trol) (Figure 1A, lane 1) results from the partial
resistance of PrP
res, i.e. removal of the nonstructured
N-terminus. The relative ratio of converted PrP
C was
approx. 5% of the PrP
C that was initially used in the reac-
tion. Conversions were carried out with mouse passaged
scrapie strain Me7 as described before [19]. The physio-
logical relevance of the assay was demonstrated with
ovine PrP polymorphisms 154H and 171R, which
strongly affect the scrapie susceptibility in sheep. In vitro,
the conversion of the 154H (Figure 1A, lane 3) and 171R
alleles were almost completely absent (Figure 1A, lane 4)
compared to 136A conveying susceptibility in vivo (Fig-
ure 1A, lane 2). The relative conversion rates were 1.9%
and 2.14% respectively as shown in Figure 1B.
To examine, whether the alleles 154H or 171R, which
are linked to low susceptibility, had an inhibitory effect
on the cell-free conversion of the ovine 136A allele, 1:1
mixtures of 136A with variants 154H or 171R (corre-
sponding to heterozygous 136A/154H and 136A/171R
animals) were carried out. Both combinations 136A/
171R (Figure 2A, lanes 4-5) and 136A/154H (Figure 2A,
lanes 6-7) showed a clear reduction to 17.5% (154H)
and 12.3% (171R) in the conversion rates (Figure 2B)
compared to 136A alone (Figure 2A, lane 1, Figure 2B).
As a control a 1:1 mixture of 136A with bovine serum
albumine as additive was used (retaining the same total
amount of protein of the sample) in order to analyse the
conversion rate of 50% of the original 136A PrP. The
determined reduction was 59%, which correlates to the
half of the amount of 136A (Figure 2A, lanes 2-3, Figure
2B). The significant reduction by 154H and 171R allele,
which exceeded 50% by far, underlines their direct
PrPres
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Figure 1 Cell-free conversion of ovine and caprine PrP
C variants by scrapie prions. (A) Detection of cell-free converted PrP
res. Non-
proteinase K (PK) treated wildtype 136A and wildtype IHNRRQ samples are shown in lane 1 and lane 5 respectively. PrP
res fragments of 136A
(lane 2) and its variants 154H (lane 3) and 171R (lane 4) are depicted. PrP
res fragments of caprine IHNRRQ (lane 6) and its variants 142M (lane 7),
143R (lane 8), 146S (lane 9), 146D (lane 10), 151H (lane 11), 211R (lane 12) and 222K (lane 13). The ovine and caprine PrP was detected using
monoclonal antibody (mab) P4. Molecular mass marker is indicated on the left. Arrow indicates PrP
res fragments. (B) Mean relative conversion
efficiencies (± standard error of the mean, SEM) for each set of conversion reaction. Relative conversion rates of ovine PrP variants were
calculated in relation to the ovine 136A reference allele and the goat derived variants in relation to the caprine IHNRRQ reference allele. Bars
depict the SEM of at least 4 reactions. The differences were analyzed by unpaired student t-test. *: p < 0.05; **: p < 0.01; ***: p < 0.001. ns: not
significant.
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inhibitory effect of 171R and 154H alleles over the 136A
alleles at the protein level.
The same studies were carried out with the caprine
PrP variants. The conversion of the wildtype allele
IHNRRQ with the mouse-passaged scrapie strain Me7
was confirmed by the formation of a PK-resistant PrP
res
fragment (Figure 1A, lane 6), which harboured a shift in
the molecular mass of about 6-7 kDa in contrast to the
untreated control (Figure 1A, lane 5). Amino acid
exchanges 142M (Figure 1A, lane 7), R151H (Figure 1A,
lane 11) and 211Q (Figure 1A, lane 12) resulted in sig-
nificantly reduced conversion rates of up to 34.9% (for
142M), 56.9% (for R151H) and 65.4% (for 211Q) in
comparison to the IHNRRQ allele alone (Figure 1A,
lane 6). Only the 143 allele showed a non significant
reduction to 71.1% (Figure 1A, lane 8). Exchanges at
position 146 (146D, 146S) and 222 (222K) inhibited a
conversion completely (Figure 1A, lanes 9, 10, 13). The
relative conversion rates are displayed in Figure 1B. An
incomplete proteolysis of full-length PrP by Proteinase
K was observed infrequently (e.g. Figure 1A lane 10),
and is a concession to using native buffer conditions
and the absence of denaturants like urea or guanidinium
hydrochloride.
Possible dominant-negative inhibitions were also ana-
lyzed in 1:1 mixtures of the caprine IHNRRQ allele co-
incubated with the alleles 146S (IHNRRQ/146S), 146D
(IHNRRQ/146D) and 222K (IHNRRQ/222K), which are
associated with resistance to scrapie. The IHNRRQ con-
version was significantly inhibited by 146S (Figure 2A,
lanes 9-10), 146D (Figure 2A, lanes 11-12) and 222K
(Figure 2A, lanes 13-14) with corresponding relative
conversion rates of 22.4%, 31.4% and 33.1% respectively
(Figure 2B). Again, the significant reduction of more
than 50% indicates the direct interference of conversion
incompetent alleles with the wild-type IHNRRQ allele,
leading to dominant-negative inhibition.
Discussion
Cell-free conversion assays were widely used for the
determination of PrP conversion efficiencies and
Figure 2 Dominant inhibition of the cell-free conversion by alleles associated with low susceptibility. (A) PrP
res fragments generated
from 136A (lane 1), a 1:1 mxiture of 136A with BSA (lanes 2-3), a 1:1 mixture of 136A with 171R (lanes 4-5), a 1:1 mixture of 136A with 154H
(lanes 6-7). PrP
res fragments derived from IHNRRQ (lane 8), a 1:1 mixture of IHNRRQ with 146S (lanes 9-10), a 1:1 mixture of IHNRRQ with 146D
(lanes 11-12) and a 1:1 mixture of IHNRRQ with 222K (lanes 13-14). Detection was carried out using mab P4. Arrow indicates PrP
res fragments.
(B) Mean relative conversion efficiencies (± SEM) for each set of at least four conversion reactions. Relative conversion rates were calculated in
relation to the ovine 136A reference allele and the caprine IHNRRQ reference allele. The differences were analyzed by unpaired student t-test. *:
p < 0.05; **: p < 0.01; ***: p < 0.001. ns: not significant.
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conversion of ovine and caprine polymorphisms in vitro
and their association with susceptibility to scrapie in
vivo. The used cell-free conversion assay is based on the
conversion of recombinant ovine and caprine PrP by a
PrP
Sc seed and involves antibodies, that discriminate
between newly converted PrP
res and the used PrP
Sc seed
v i aas p e c i e ss p e c i f i ce p i t o p e .W et h e r e f o r er e q u i r e da
scrapie strain which was passaged in another species. We
selected the mouse passaged scrapie strain Me7 for our
studies, since it was isolated from various classical scrapie
cases. Moreover, Me7 retained its biological and physico-
chemical characteristics during multiple passages in a
variety of different species [22,26-28]. Although the con-
version of ovine PrP by mouse passaged strain Me7
crosses the species barrier, the newly converted recombi-
nant ovine PrP
res displays the same biochemical charac-
t e r i s t i c sa sP r P
Sc derived from original scrapie. This
includes partial PK-resistance, detection by mab P4 as
well as mab L42 and a shift in the molecular mass of the
unglycosylated fragment compared to BSE derived frag-
ments (data not shown). The available data suggest that
the biological properties of the newly formed PrP
res
molecules are not modified after conversion with mouse
adapted strains and that this model represents a suitable
system to study ovine and caprine PrP polymorphisms
on scrapie susceptibility in vitro.
Molecular structure analysis studies were obtained pri-
marily for ovine PrP
C variants and compared to corre-
sponding convertibility data. The absence of conversion
of the 171R allele was explained by the exchange of glu-
tamine (Q) by the basic residue arginine (R) at position
171, which interferes with the formation of the extended
b-sheet rich structure during the conversion [29]. In
addition, using spectroscopic analysis, it could be
demonstrated that the 171R conformation was less
stable than the 136A conformation at physiological tem-
peratures. The low conformational stability inhibited
amyloid fibril formation [30]. In the case of the 154H
allele, the exchange of arginine to histidine at position
154 was perturbing the a-helix 1 by disrupting the salt-
bridge between residues D150 and R154 (positions
according to human PrP) [31]. Although CD-spectra of
different alleles showed similar a-helical structures the
exchange of one amino acid in the 171R and 154H allele
caused a reduced thermodynamic and thermal stability
in the protein [32].
This is similar to the situation in vivo: expression of
the 171R allele is related to scrapie resistance, and the
154H allele causes a reduced susceptibility to the dis-
ease. In contrast the 136A genotype was found to be
highly susceptible, when exposed to natural or experi-
mental classical scrapie [33]. The homozygous genotype
154H/154H was proposed to be nearly as protective
against scrapie as 171R/171R [23]. 154H was also asso-
ciated with resistance to natural scrapie in Cypriot goats
[13]. However, the influence of the 154H allele on the
scrapie susceptibility is ambiguous, which is highlighted
by the occurrence of scrapie positive sheep with a
homozygous 154H/154H genotype in a Merinoland
sheep flock [34]. Even in sheep, carrying the 171R/171R
genotype, which is generally regarded as highly resistant
to classical scrapie, two classical scrapie cases were
reported [35]. Both alleles, however, are linked to sus-
ceptibility for atypical/Nor98 scrapie in affected hetero-
zygous animals [36,37]. Moreover, 171R/171R genotypes
[38] and 154H/154H genotypes [39] are susceptible to
BSE after experimental infection. These data indicate
that the influence of both alleles to scrapie susceptibility
displays a complex interplay with different TSE strains
and probably depends on additional genetic and epide-
miological risk factors.
Co-incubation of the 171R and 154H variant with the
136A allele, termed 136A/171R and 136A/154H,
resulted in a significantly reduced conversion rate in
contrast to the single 136A genotype. A similar effect
has been observed with hamster allele 172R, which inhi-
bits the conversion of wild type hamster PrP in vitro
[40]. According to the stone fence model [41], the loss
of conversion efficiency can be explained by the incor-
poration of conversion incompetent 171R or 154H
molecules into the 136A aggregates, which delay or
block fibril elongation. The interference of alleles linked
to high susceptibility with alleles linked to low suscept-
ibility in vitro is in good accordance with the situation
in vivo. Sheep carrying the 136A/154H or the 136A/
171R allele show a reduced susceptibility to scrapie
compared to the 136A/136A allele [2]. The dominant-
negative inhibition works therefore on protein level and
is probably not caused by preferential expression of the
susceptible alleles. This could be demonstrated by
assessment of PrP transcripts from heterozygous 136A/
171R sheep and the confirmation of equal use of both
alleles [42]. These results also argument also against the
existence of the proposed factor X [43]. However, the
age related increase of 136A/154H scrapie cases [2]
highlights the erratic role of 154H polymorphism and
suggests the involvement of additional factors.
Due to a limited number of goats, which harbour dis-
ease associated polymorphisms, a significant correlation
of specific polymorphisms to susceptibility is difficult to
obtain in vivo. The 142M polymorphism is found with a
low frequency in the goat population, but experimental
infection of 142M goats with scrapie and BSE strains
showed an increased incubation period [10]. This is in
agreement with the reduced convertibility of the recom-
binant 142M allele in vitro. A similar correlation was
found at codon 143. Studies on the relative scrapie
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Greek goat herds revealed a moderately protective effect
of the 143R polymorphism [11]. We have observed a
similar effect in the here reported in vitro studies. A
similar protective effect may also exist for the R151H
polymorphism in Cypriot goats [13,44]. Another poly-
morphism (211Q) in French goats is also suspected to
reduce the scrapie susceptibility [12]. This is consistent
with our findings, in which the exchange of arginine (R)
to glutamine (Q) at position 211 in recombinant PrP
caused a reduced conversion rate.
Two novel polymorphisms at position 146 (146D and
146S) were found in scrapie-negative animals in Cypriot
goat herds [44]. The protective effects of exchanges
from asparagine (N) to aspartic acid (D) or serine (S)
were confirmed in the cell-free conversion by the com-
plete absence of PrP
res fragments of the respective PrP
C
variant. The inhibitory potential of these variants was
confirmed by dominant-negative effects in vitro, where
co-incubation with the susceptible IHNRRQ allele
caused a significant decrease in the conversion rate
for both the IHNRRQ/146D and the IHNRRQ/146S
variants.
An exchange from glutamine (Q) to lysine (K) at posi-
tion 222 (222K) revealed another protective polymorph-
ism in goats. Looking at scrapie outbreaks in Italian
goats, this polymorphism was found only in healthy ani-
mals [14]. The conversion of recombinant 222K allele
was completely abolished in vitro and significantly
reduced the conversion rate of the susceptible IHNRRQ
allele during co-incubation. Similar effects were found
in human PrP, where the E219K allele was reported to
protect against Creutzfeldt-Jakob-Disease [45]. In addi-
tion, the influence of the Q218K variant of the mouse
prion protein was analysed in vitro and found to signifi-
cantly reduce aggregation kinetic and induce a domi-
nant-negative effect on murine wildtype prion protein
[46]. This way, insertion of an additional positive charge
at position 222 of the caprine prion protein is assumed
to interfere with PrP
C/PrP
Sc interaction.
In summary, the here reported in vitro conversion stu-
dies support the association of specific ovine and capr-
ine PRNP polymorphisms with a reduced classical
scrapie susceptibilities in vivo. Moreover we could
demonstrate an interference of susceptible PrP alleles by
co-incubation with inhibitory alleles in vitro, which
apparently corresponds to prolonged incubation times
of heterozygous animals in vivo.
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